Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Terminated2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT04752163Phase 1/2Terminated
DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+6 more
PrincipalinvestigatorStart date: 2021-03-25
NCT03301597Phase 2Terminated
NLA101 in Adults Receiving High Dose Chemotherapy for AML
Leukemia, Myeloid, Acute
StudychairStart date: 2018-01-24
NCT02709993Phase 1/2Withdrawn
Consolidation Therapy in Patients With Hematologic Malignancies
CancerHematologic Malignancies
PrincipalinvestigatorStart date: 2017-07-28

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+3 more

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score15%

Martin S Tallman, MD

Memorial Sloan Kettering Cancer Center

Related
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, Acute

Worked with same sponsors:

Nohla Therapeutics, Inc.
Collaborated on 1 trial
Similarity Score14%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsCancer
Similarity Score8%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsRefractory Acute Myeloid Leukemia
Similarity Score8%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteCancer
Similarity Score5%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteRefractory Acute Lymphoblastic Leukemia
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteCancer

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score5%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

CancerHematopoietic and Lymphoid Cell Neoplasm
Similarity Score5%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic Neoplasms

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score5%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04752163Phase 1/2PrincipalInvestigator

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Hematopoietic and Lymphoid Cell NeoplasmRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+6 more
Terminated
NCT03301597Phase 2StudyChair

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Leukemia, Myeloid, Acute
Terminated
NCT02709993Phase 1/2PrincipalInvestigator

Consolidation Therapy in Patients With Hematologic Malignancies

CancerHematologic Malignancies
Withdrawn

All 3 trials loaded